Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
9.91
-0.17 (-1.71%)
At close: Apr 29, 2026, 4:00 PM EDT
9.90
-0.01 (-0.08%)
After-hours: Apr 29, 2026, 4:10 PM EDT

Beta Bionics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-66.44-73.2-54.76-44.1-64.75
Depreciation & Amortization
3.262.882.282.092.09
Other Amortization
----0.01
Loss (Gain) From Sale of Assets
0.030.030.020.010.04
Loss (Gain) From Sale of Investments
-0.99-1.99-2.91-0.75-
Stock-Based Compensation
18.9916.386.385.666.1
Provision & Write-off of Bad Debts
0.040.040.070.05-
Other Operating Activities
1.0713.9312.789.9-0.91
Change in Accounts Receivable
-6.73-5.16-7.62-4.49-
Change in Inventory
-9.06-9.88-11.44-1.19-
Change in Accounts Payable
-1.142.11.520.72-0.08
Change in Unearned Revenue
1.782.062.460.34-0.18
Change in Other Net Operating Assets
4.421.92.94-0.68-2.53
Operating Cash Flow
-54.78-50.93-48.27-32.45-60.21
Capital Expenditures
-6.34-5.3-3.4-0.4-0.77
Sale of Property, Plant & Equipment
--0.0500
Investment in Securities
44.5-157.51-0.13-69.3-
Investing Cash Flow
38.16-162.81-3.48-69.69-0.77
Issuance of Common Stock
4.38214.870.10.030.39
Other Financing Activities
---4.15-11.41
Financing Cash Flow
4.38214.8755.62101.0356.78
Net Cash Flow
-12.251.143.87-1.11-4.2
Free Cash Flow
-61.12-56.22-51.67-32.85-60.98
Free Cash Flow Margin
-55.45%-56.08%-79.34%-273.84%-34067.04%
Free Cash Flow Per Share
-1.39-1.39-8.12-6.19-12.20
Levered Free Cash Flow
-44.06-40.9-35.24-19.66-
Unlevered Free Cash Flow
-44.06-40.9-35.24-19.66-
Change in Working Capital
-10.73-8.99-12.15-5.31-2.79
Source: S&P Capital IQ. Standard template. Financial Sources.